
Small Pool Heat-Treated Intermediate Purity Factor VIII Concentrate
Small pool heat-treated intermediate purity concentrate may be the most suitable and cost-effective solution for some countries attempting sufficiency and
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Video
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

Small pool heat-treated intermediate purity concentrate may be the most suitable and cost-effective solution for some countries attempting sufficiency and

This monograph provides guidelines for the production of single-donor cryoprecipitate.

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Russian Treatment for bleeding

The 2023 edition is available in: English, Spanish, French, Arabic, Russian, Simplified Chinese This edition of the resource has also been

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese このファクトシートには、血友病患者に基本的な治療およびケアを提供するメリットが記載されています。適切なケアには、血友病治療センターおよび治療用製剤の利用、医療関係者、患者、家族に対する教育が含まれます。

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese 安全で規制を順守している血漿由来凝固因子濃縮製剤で血友病患者を治療することは、出血性疾患患者への社会経済的影響、さらには政府やコミュニティ、家族から求められる長期的支援を直接軽減します。